This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
social-media: Archive
PINS Rides on Growing International Monetization: Can Momentum Continue?
by Zacks Equity Research
Pinterest's international user growth and rising ARPU are fueling monetization, but a wide gap with North America leaves room for growth.
PINSPositive Net Change SNAPPositive Net Change RDDTPositive Net Change
social-media tech-stocks
Muse Powers META Shares Higher: A Closer Look
by Derek Lewis
Meta Platforms (META) shares have been red-hot as of late, seeing big gains on the recent release of Muse, apersonal AI assistant that can autonomously complete multi-step tasks across the web, apps, and smart glasses.
METAPositive Net Change
social-media tech-stocks
Are Netflix Shares Still Worth Watching?
by Derek Lewis
Netflix (NFLX) has been a somewhat complicated story for some time now, with shares unable to find consistent stability. As a current Zacks Rank #4 (Sell), investors have better options available for near-term gains.
NFLXPositive Net Change
consumer-discretionary social-media tech-stocks
Meta Platforms Jumps 33% in a Month: Should You Buy or Hold the Stock?
by Aniruddha Ganguly
META's 33% monthly surge reflects strong ads and AI momentum, but soaring capex, rising debt and weak cash flow remain key concerns.
METAPositive Net Change AMZNPositive Net Change GOOGLNegative Net Change SNAPPositive Net Change
artificial-intelligence social-media tech-stocks
Facebook-Parent Meta Surges Ahead of Connect 2026 Event
by Bryan Hayes
The reasons behind the latest rebound suggest this may be more than a relief rally.
METAPositive Net Change
advertising artificial-intelligence datacenter earnings investing social-media tech-stocks
Sharplink Inc (SBET) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
SBETNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Buy, Hold or Sell META Stock Ahead of Meta Connect 2026?
by Rimmi Singhi
Meta Platform's Muse surge sets the stage for Connect 2026, as investors weigh fresh product catalysts against heavy AI spending, ad dependence and valuation.
METAPositive Net Change AMZNPositive Net Change AAPLNegative Net Change GOOGLNegative Net Change
artificial-intelligence social-media tech-stocks
Should Investors Chase the AI-Fueled Rally in AMD or META Stock?
by Shaun Pruitt
AMD and META were two of Monday's biggest mega-cap winners, with both stocks surging roughly 10% as enthusiasm around artificial intelligence returned in force.
AMDNegative Net Change METAPositive Net Change AAPLNegative Net Change NVDANegative Net Change
ad-tech advertising artificial-intelligence datacenter internet investing large-cap semiconductor social-media software tech-stocks
Can Pinterest's Latest Visual Search Ads Boost Its Market Position?
by Zacks Equity Research
PINS' Visual Search Ads connect commercial intent with visual discovery, giving brands new ways to reach shoppers closer to purchase.
PINSPositive Net Change SNAPPositive Net Change METAPositive Net Change
ad-tech artificial-intelligence automation social-media tech-stocks
Chagee Holdings Limited - Sponsored ADR (CHA)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
CHANegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines